[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100427259":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":50,"collaborators":18,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":18,"enrollmentInfo":62,"targetDuration":18,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":18,"overallStatus":33,"whyStopped":18,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"University Health Network, Toronto","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Stereotactic ablative radiotherapy (SBRT) Arm","EXPERIMENTAL","Stereotactic ablative radiotherapy (SBRT) is a type of radiation treatment that delivers precise, high dose radiation to targeted areas. In this study, a single treatment of SBRT will be delivered to the abnormal area of a participant's heart that is causing dangerous heart rate and rhythm changes (arrhythmia).",[13],"Radiation: Stereotactic Ablative Radiotherapy",{"label":15,"type":16,"description":17,"interventionNames":18},"Observational Arm","NO_INTERVENTION","Potential participants who are eligible to be included in the study, but who choose not to have the SBRT procedure, can still receive standard medical treatment alone and be followed up with study visits and questionnaires.",null,[20],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":18},"RADIATION","Stereotactic Ablative Radiotherapy",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Benjamin Lok, MD","CONTACT","416-946-2919","benjamin.lok@rmp.uhn.ca",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Princess Margaret Cancer Center, University Health Network","RECRUITING","Toronto","Ontario","M5G 2M9","Canada","CA",{"type":40,"coordinates":41},"Point",[42,43],-79.39864,43.70643,{"lat":43,"lon":42},[46],{"name":26,"role":27,"phone":47,"phoneExt":48,"email":49},"416-946-4501","5819","Benjamin.Lok@rmp.uhn.ca",{"type":51,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100427259","stereotactic-ablative-radiotherapy-of-cardiac-arrhythmias-100427259",false,"NCT04843683","StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias","StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA): a Phase II Trial of Non-Invasive Treatment of Medically Refractory Patients","START-CA","Inclusion Criteria:\n\n* Patients with heart rate and rhythm condition (arrhythmia) who have failed standard of care treatment with medication OR at least one prior invasive catheter ablation procedure.\n* Patients deemed medically fit to receive stereotactic ablative radiotherapy as determined by their Radiation Oncologist.\n\nExclusion Criteria:\n\n* Patients who have previously received high dose radiotherapy to the target area and cannot safely receive further treatment OR are unable to receive radiotherapy due to other contraindications.","ALL","18 Years",{"count":63,"type":64},60,"ESTIMATED","INTERVENTIONAL",[67],"NA","This is a prospective, single-center, phase II trial that will be monitoring the safety and efficacy of using stereotactic ablative radiotherapy (SBRT) to treat patients with a medical condition affecting heart rate and rhythm (refractory arrhythmias) within the University Health Network (Princess Margaret Cancer Centre and Toronto General Hospital). The primary objective will be to prospectively monitor patient cardiac outcomes following SBRT.",[70],"Cardiac Arrhythmia","2026-03-03",{"date":73,"type":74},"2026-03-05","ACTUAL",{"date":76,"type":74},"2021-12-14",{"date":78,"type":64},"2027-12",{"name":5,"class":6},1]